The self-expanding, recapturable coronary sinus reducer was associated with a safe implant procedure and "promising" outcomes after six months. Additional research is already underway.

The annual meeting at the Los Angeles Convention Center just wrapped up. Here’s a small sample of some of the biggest announcements.

Serious complications are rare after TAVR, but they can be catastrophic or fatal when they do occur. The care team at Sentara Heart Hospital found that bringing in new 3D software made it much easier to plan ahead for such issues. 

Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.

Jennifer Ashton, MD, an OB-GYN who became a household name thanks to years of appearances on ABC News and Good Morning America, hopes this new initiative can help cardiologists learn more about such topics as menopause and hormone therapy. 

In fact, researchers wrote, TAVR and SAVR were linked to comparable long-term outcomes for heart patients who have previously been exposed to mediastinal radiation. 

The introduction of a 3D pediatric transesophegeal echo probe is having a major impact on how these pediatric congenital heart patients are being treated.

Education through the organization provides the knowledge needed for clinicians to work with IT teams to implement major system projects.